Crossmark

Anti-inflammatory activity of berberine in non-alcoholic fatty liver disease via the Angptl2 pathway

Published Online: 2020-05-19

Published Print: 2020-12

Authors

Lu, Zengsheng

He, Beihui

Chen, Zhiyun

Yan, Maoxiang

Wu, Liyan http://orcid.org/0000-0002-9832-397X
Funding

Funding for this research was provided by:

Chinese Medicine Research Program of Zhejiang Province (2016ZB004, 2019ZA024)

the Medical Health Science and Technology Project of Zhejiang Provincial Health Commission (2018KY322)

the Program of Zhejiang Province Natural Science Foundation (LY17H290007)
License Information

Text and Data Mining valid from 2020-05-19

Version of Record valid from 2020-05-19
More Information

Article History

Received: 4 July 2019

Accepted: 12 May 2020

First Online: 19 May 2020

Ethics approval and consent to participate

: The experimental protocols were established according to the Declaration of Helsinki, and the experiments were approved by the Experimental Animal Ethics Committee of the Animal Use and Care Committee of Tongde Hospital of Zhejiang Provice, (Approval NO.:[2019]013).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current